RemoteEx+ for Inactive Adults
(RemoteEx+ Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new exercise app, RemoteEx+ Programming, designed to help people in rural areas reduce their risk of Alzheimer's and related dementias. The researchers aim to determine if the app can boost exercise habits, improve quality of life, and lower blood pressure—factors linked to dementia risk. The trial seeks underactive adults who live in rural areas, speak English, and have a smartphone. Participants should be willing to try the app and have approval from their primary care doctor to take part. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance health outcomes in rural communities.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the RemoteEx+ program is safe for participants?
Research shows that remote exercise programs like RemoteEx+ are generally safe and easy to follow. In a previous study, older women participated in a similar remote exercise program. The study found that the program did not harm the participants. Additionally, participants adhered to the program as planned.
These findings suggest that RemoteEx+ is likely safe for those who try it. While individual experiences may vary, evidence indicates that similar programs have been used successfully without major issues.12345Why are researchers excited about this trial?
RemoteEx+ Programming is unique because it's an innovative approach to increasing physical activity among inactive adults by using remote technology. Unlike traditional exercise programs that require in-person attendance, RemoteEx+ leverages digital platforms to deliver customized exercise routines directly to participants' homes. This remote delivery not only increases accessibility for those who may have mobility or transportation issues but also allows for personalized tracking and adjustments based on individual progress. Researchers are excited about the potential for RemoteEx+ to make exercise more convenient and engaging, potentially leading to higher adherence rates and improved health outcomes compared to conventional methods.
What evidence suggests that the RemoteEx+ program is effective for reducing dementia risk?
Research has shown that remote exercise programs can help older adults enhance their daily activities, movement, and overall physical activity. One study found that these programs increased physical activity in people who work at desks all day. Another study showed that older adults who joined a remote exercise program maintained their ability to move and stay active over time. These results suggest that the RemoteEx+ Program, which participants in this trial will engage with, could improve exercise habits and overall well-being, important factors in lowering the risk of dementia. The program's focus on motivation and education may make it especially beneficial in rural areas.26789
Are You a Good Fit for This Trial?
This trial is for adults living in rural Kansas and Nebraska who are not currently active. Participants should be at risk of cognitive impairment and willing to use a smartphone app designed to improve exercise habits.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the RemoteEx+ exercise program delivered through a smartphone application, including video demonstrations, workout regimes, motivational messaging, and weekly ADRD risk reduction education
Follow-up
Participants are monitored for exercise adherence, efficacy, enjoyment, quality of life, blood pressure, functional mobility, and knowledge of dementia
What Are the Treatments Tested in This Trial?
Interventions
- RemoteEx+ Programming
Find a Clinic Near You
Who Is Running the Clinical Trial?
Creighton University
Lead Sponsor